These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 931525

  • 1. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 2. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 3. The complement abnormalities of lipodystrophy.
    Sissons JG, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, Peters DK.
    N Engl J Med; 1976 Feb 26; 294(9):461-5. PubMed ID: 1246331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr 26; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 6. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov 26; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 7. [Morphological varieties of membranoproliferative glomerulonephritis].
    Imbasciati E, Tarantino A, Ponticelli C, Giani M, Bardare M, Gaboardi F.
    Minerva Nefrol; 1981 Nov 26; 28(3):415-9. PubMed ID: 7329619
    [No Abstract] [Full Text] [Related]

  • 8. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
    Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD.
    Am J Kidney Dis; 1987 Feb 26; 9(2):115-20. PubMed ID: 3826060
    [Abstract] [Full Text] [Related]

  • 9. [Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].
    Martínez Debora MJ, Vázquez Martul M, Ecija Peiró JL, González Pérez J, Lirio Rodríguez J, González Mediero I.
    An Esp Pediatr; 1989 Jun 26; 30(6):499-502. PubMed ID: 2679278
    [Abstract] [Full Text] [Related]

  • 10. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP, Kourilsky O, Morel-Maroger L, Adam C.
    N Engl J Med; 1978 May 04; 298(18):1034. PubMed ID: 643001
    [No Abstract] [Full Text] [Related]

  • 11. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M, Balow JE, Tsokos GC.
    J Immunol; 1986 Jun 15; 136(12):4451-5. PubMed ID: 3011894
    [Abstract] [Full Text] [Related]

  • 12. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar 15; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

  • 13. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK, Williams DG.
    Adv Nephrol Necker Hosp; 1974 Mar 15; 4():67-78. PubMed ID: 4220000
    [No Abstract] [Full Text] [Related]

  • 14. [Partial lipodystrophy (cephalothoracic type) with asymptomatic dense deposit disease (author's transl)].
    Houssin A, Saint-André JP, Buzelin F, Guenel J.
    Ann Med Interne (Paris); 1981 Mar 15; 132(1):44-7. PubMed ID: 7224470
    [Abstract] [Full Text] [Related]

  • 15. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK, Cavallo T.
    Am J Pathol; 1976 Aug 15; 84(2):283-98. PubMed ID: 133617
    [Abstract] [Full Text] [Related]

  • 16. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb 15; 101(2):271-8. PubMed ID: 19190809
    [Abstract] [Full Text] [Related]

  • 17. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
    Watanabe S, Ohi H, Seki M, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1985 Oct 15; 27(10):1345-52. PubMed ID: 4094159
    [No Abstract] [Full Text] [Related]

  • 18. [Complement activating factors in hypocomplementemic membranoproliferative glomerulonephritis (MPGN) patients' sera--comparison with C3NeF positive and negative cases].
    Ohmori F, Ohi H, Seki M, Watanabe S, Hatano M.
    Nihon Jinzo Gakkai Shi; 1987 Apr 15; 29(4):493-8. PubMed ID: 3656707
    [No Abstract] [Full Text] [Related]

  • 19. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A, Ohi H, Okano K, Watanabe S, Seki M, Hatano M, Koitabashi Y.
    J Clin Lab Immunol; 1988 Sep 15; 27(1):35-7. PubMed ID: 3251045
    [Abstract] [Full Text] [Related]

  • 20. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 15; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.